Helen M. Thackray

Insider Reports History

Entity
Individual
Location
C/O Glycomimetics, Inc., 401 Professional Drive, Suite 250, Gaithersburg, MD
Signature
/s/ Alane P. Barnes, by power of attorney
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Helen M. Thackray:

Stock Role Class Num Shares Value Price $ Report Date Ownership
BIOCRYST PHARMACEUTICALS INC Chief R&D Officer Common Stock 272K $1.59M $5.86 May 14, 2024 Direct
ImmunoGen, Inc. Director Common Stock 0 $0 $29.30 Feb 12, 2024 Direct
ImmunoGen, Inc. Director Deferred Share Unit 0 $0 $29.30 Feb 12, 2024 Direct
ImmunoGen, Inc. Director Restricted Stock Unit 0 $0 $29.30 Feb 12, 2024 Direct
BIOCRYST PHARMACEUTICALS INC Chief R&D Officer Emp. Stock Option (Right to Buy) 238K Dec 14, 2023 Direct
ImmunoGen, Inc. Director Stock Option (Right to Buy) 0 Feb 12, 2024 Direct

Insider Reports Filed by Helen M. Thackray

Symbol Company Period Transactions Value $ Form Type Date Filed Role
BCRX BIOCRYST PHARMACEUTICALS INC May 14, 2024 1 $176K 4 May 15, 2024 Chief R&D Officer
BCRX BIOCRYST PHARMACEUTICALS INC Mar 31, 2024 1 -$38.2K 4 Apr 2, 2024 Chief R&D Officer
IMGN ImmunoGen, Inc. Feb 12, 2024 6 $0 4 Feb 12, 2024 Director
IMGN ImmunoGen, Inc. Dec 29, 2023 1 $7.47K 4 Jan 3, 2024 Director
BCRX BIOCRYST PHARMACEUTICALS INC Dec 19, 2023 1 -$33.8K 4 Dec 20, 2023 Chief R&D Officer
BCRX BIOCRYST PHARMACEUTICALS INC Dec 14, 2023 3 -$19.5K 4 Dec 18, 2023 Chief R&D Officer
IMGN ImmunoGen, Inc. Sep 29, 2023 1 $7.49K 4 Oct 2, 2023 Director
IMGN ImmunoGen, Inc. Jun 30, 2023 1 $7.49K 4 Jul 5, 2023 Director
IMGN ImmunoGen, Inc. Jun 14, 2023 2 $0 4 Jun 16, 2023 Director
BCRX BIOCRYST PHARMACEUTICALS INC Apr 3, 2023 1 -$58K 4 Apr 5, 2023 Chief R&D Officer
IMGN ImmunoGen, Inc. Mar 31, 2023 1 $7.5K 4 Apr 4, 2023 Director
BCRX BIOCRYST PHARMACEUTICALS INC Dec 19, 2022 2 $0 4 Dec 21, 2022 Chief R&D Officer
BCRX BIOCRYST PHARMACEUTICALS INC Dec 15, 2022 1 -$34K 4 Dec 19, 2022 Chief R&D Officer
IMGN ImmunoGen, Inc. Jun 15, 2022 2 $108K 4 Jun 17, 2022 Director
BCRX BIOCRYST PHARMACEUTICALS INC Apr 1, 2022 1 -$123K 4 Apr 4, 2022 Chief R&D Officer
BCRX BIOCRYST PHARMACEUTICALS INC Dec 14, 2021 2 $0 4 Dec 16, 2021 Chief R&D Officer
IMGN ImmunoGen, Inc. Sep 22, 2021 2 $263K 4 Sep 23, 2021 Director
IMGN ImmunoGen, Inc. Sep 22, 2021 0 $0 3 Sep 23, 2021 Director